Drawing for GUIDANTRX

USPTO serial 87007659

GUIDANTRX

Reviewed by CopyMark Law Group

Reg. 5487101Status 702Registered
Filing date
Status date
Registration date
Jun 5, 2018
Examiner
BIBB,SCOTT
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with GUIDANTRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenneth Todd Veirs

Kenneth Todd Veirs Humana Inc101 E. Main StreetLouisville, KY 40202-4268United States

Goods and services

ClassDescriptionStatusFirst use
035Retail pharmacy services, mail order of pharmaceuticals; specialty pharmaceutical distributorship services, pharmaceutical utilization services, namely, pharmaceutical cost management services and drug utilization review services; management services provided to health care companies for controlling drug costs, namely, prescription drug formulary management servicesACTIVEJan 31, 2017
036Pharmacy benefit management services, processing and reporting of pharmaceutical claims adjudication on behalf of pharmaceutical companies, their subcontractors, or affiliates, in conjunction with the administration of pharmaceutical co-payment or similar programs; Financial administration of pharmaceutical reimbursement collection programs for others; insurance and other commercial claims processing, namely, pharmaceutical claims processingACTIVEJan 31, 2017
044health care services, namely, disease management programsACTIVEJan 31, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 5, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 5, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 5, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 5, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 29, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 16, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 16, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 16, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 3, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jun 5, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 1, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 28, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 27, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 27, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 26, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 8, 2018IUAFUSE AMENDMENT FILED—
Mar 8, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 8, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 26, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 1, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 1, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 12, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 20, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 20, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 20, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 20, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 31, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 31, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 31, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 13, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 12, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 12, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2016DOCKASSIGNED TO EXAMINER—
Apr 26, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 25, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance